SCHEMBL6170227

SCHEMBL6170227

CSc1cccc(-c2cccnc2Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIP4K2A P48426 2/20 0.44
▸ PIP4K2C Q8TBX8 2/20 0.44
▸ IDO1 P14902 1/20 0.42
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ GRM4 Q14833 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CTSA P10619 1/20 0.40
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ SYK P43405 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.38
▸ PDE4A P27815 1/20 0.37
▸ PDE4B Q07343 1/20 0.37
▸ PDE4C Q08493 1/20 0.37
▸ PDE4D Q08499 1/20 0.37
▸ AKR1C3 P42330 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170224 0.83 PIP4K2A (0.47) PIP4K2APIP4K2CNPC1RAB9ASMN1; SMN2
SCHEMBL4734600 0.77 TDP1 (0.65) NPC1RAB9AGRM4SMN1; SMN2MEN1
SCHEMBL27935092 0.76 CTSA (0.46) NPC1RAB9ASMN1; SMN2CTSAMEN1
SCHEMBL28357121 0.75 MAP4K4 (0.53) NPC1RAB9ACTSAMEN1KMT2A
SCHEMBL3327536 0.73 DHODH (0.50) NPC1RAB9ASMN1; SMN2CTSAMEN1
SCHEMBL6170030 0.72 CYP2C9 (0.50) PIP4K2APIP4K2C
SCHEMBL857471 0.72 CDC7 (0.64) MAP4K4LRRK2TGFBR1
SCHEMBL31731007 0.72 ACVR1 (0.40) IDO1NPC1RAB9AGRM4SMN1; SMN2
SCHEMBL27945860 0.70 DHODH (0.51) NPC1RAB9ASMN1; SMN2MEN1KMT2A
SCHEMBL15109935 0.69 NISCH (0.44) IDO1NPC1RAB9ASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015431-B1 2-AMINOPYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2 MERCK FROSST CANADA INC (CA) 2005-04-20 — — EP disclosed
EP-1015431-A1 2-AMINOPYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2 Merck Frosst Canada & Co. (CA) 2000-07-05 — — EP disclosed
US-6004950-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS; ANALGESIC, ANTIPYRETICS; SIDE EFFECT REDUCTION MERCK FROSST CANADA, INC. (CA) 1999-12-21 — — US disclosed
WO-1999014195-A1 2-AMINOPYRIDINES AS INHIBITORS OF CYCLOOXYGENASE-2 MERCK FROSST CANADA & CO. (CA) 1999-03-25 — — WO disclosed
Send feedback